top of page

PT-141 

PT-141, also known as Bremelanotide, is a synthetic peptide analog of the naturally occurring alpha-melanocyte stimulating hormone (α-MSH). It is primarily studied in preclinical research settings for its potential effects related to sexual arousal and central nervous system activity. PT-141 is explicitly intended for research purposes only and is not approved or intended for human consumption or therapeutic use.

 

Overview of PT-141 Research

Composition and Origin

  • Synthetic Peptide: PT-141 (Bremelanotide) is a lab-synthesized analog of α-MSH, specifically designed to investigate central nervous system pathways involved in sexual arousal and behavior (Pfaus et al., 2007).

  • Research-Oriented Use: Exclusively designated for laboratory research to study neurological and behavioral pathways.

Key Areas of Animal Research

  • Central Nervous System Effects: Animal studies explore the potential mechanisms by which PT-141 interacts with melanocortin receptors, influencing pathways related to arousal and sexual behaviors (Pfaus et al., 2007; Molinoff et al., 2003).

  • Behavioral Responses: Preclinical research assesses the peptide’s potential effects on sexual motivation and related neurological responses.

Important Reminders for Research Use

  • Sterile Handling: Always handle peptides under sterile conditions to prevent contamination.

  • Proper Storage: PT-141 must be refrigerated according to provided storage guidelines.

  • Acknowledgment of Use: By purchasing PT-141, you explicitly acknowledge it is strictly for laboratory research purposes and is not intended for human consumption or therapeutic use.

References:

  • Pfaus, J.G., Giuliano, F., Gelez, H. (2007). Bremelanotide: an overview of preclinical CNS effects on female sexual function. Journal of Sexual Medicine, 4(s4), 269-279.

  • Molinoff, P.B., Shadiack, A.M., Earle, D., Diamond, L.E., & Quon, C.Y. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences, 994(1), 96-102.

 

Disclaimer:
PT-141 is strictly intended for research purposes and has not been evaluated by the FDA. It is not approved for human use or therapeutic applications. No claims are made regarding its effectiveness in diagnosing, treating, curing, or preventing any disease, condition, or illness. All referenced research pertains exclusively to preclinical animal studies or controlled laboratory conditions.

INGREDIENTS

PT-141 10mg / 3ml

​​​​

199 per vial 

​

Buy 2 Get 1 Free 398

7.png
Screenshot 2025-03-29 at 5.48.28 PM.png
PEPTIDE VIALS] (7).png
PEPTIDE VIALS] (8).png

PT-141
RESEARCH PEPTIDE

929929.JPG

Mobile NAD+ IV Now available

Experience the convenience of IV therapy in the comfort of your own home. Our professional team brings personalized hydration and wellness treatments directly to you, ensuring expert care without the need to travel.

Why Choose At Home IV Therapy?

  • Convenience: Receive treatment without leaving home.

​

  • Time-Saving: Skip the clinic and save time.

​

  • Privacy: Discreet care in your personal space.

​

  • Comfort: Relax in familiar surroundings.

​

  • Flexibility: Perfect for when you can’t travel.

​

  • Custom Care: Personalized treatments delivered to you.

LIVKRAFT

7710 Fay Ave

La Jolla, CA 92037

HOURS

Monday - Thursday   9am - 6pm

Friday   9am - 2pm

Saturday - Sunday    9am - 4pm

CONTACT US

(858) 401-2383 

stayhealthy@livkraft.com

  • Instagram
  • Facebook
  • Twitter

The statements, commentary, and content on this website have not been evaluated by the FDA. The devices utilized at LIVKRAFT are not intended to diagnose, treat or prevent any disease. Livkraft is not a medical practice and Livkraft employees are not doctors or medical professionals and are not diagnosing, treating or preventing any disease. The LIVKRAFT name and Logo are Registered Trademarks of LIVKRAFT and its owners. All medical professionals located or operating out of LIVKRAFT are separate entities.  

 

OPYRIGHT © 2025 BY LIVKRAFT AND ITS OWNERS . ALL RIGHTS RESERVED.

Terms & Conditions  |  Privacy Policy  |  Cookie Policy

bottom of page